Where can I find a list on zhnvlp. What are essential medicines? HIV drugs

There are separate groups of patients who are entitled to free or subsidized drugs. How to get life-sustaining medicines prescribed by a doctor?

Step-by-step instruction

1. After the operation (after discharge from the hospital), it is necessary to present a discharge summary to the treating local therapist or oncologist (the summary should indicate that the drug is vital, and the dosage should be scheduled, because the clinic is guided precisely by this).

2. It is necessary to collect a package of documents for presentation to the Medical and Social Expertise (ITU) to obtain a disability group.

Unfortunately, it is disability that is the undeniable ticket for free medicines, although timely treatment could in some cases prevent disability.

3. Submit an ITU certificate to your primary care physician and have you notified that you have been assigned additional drug lists if it is the end of the year. These lists are sent to the Ministry of Health of the region, and bidding for purchases is held there. medicines between pharmaceutical companies.

You just need to demand that your name is on the list. All this can take about three months.

4. A special story if you end up in a hospital. The hospital must provide you with the medicines you need. If you bought it at your own expense, but took cash and sales receipts at the pharmacy (both types of receipts will be required). After discharge from the hospital, checks can be presented for payment to the insurance company where you received your medical policy. The application form is simple, you can even send letters by registered mail with all copies of checks and discharge statements attached. There is one feature: the date of purchase of the drug must coincide with the days when you were in the hospital.

5. If you are treated at home, then you will have to go for a prescription every month. For a number of drugs, it is mandatory to conduct a medical commission (MC) in the clinic. Find out this too: the VK protocol should be in the card.

6. If something does not add up, send requests to the name of the head physician, preferably in writing, and keep copies for yourself.

If this does not help, you should send a letter to the regional Ministry of Health asking why you are not being given a life-saving drug. You can ask if there has been an auction for your drug and when the dispensing will begin (you need to know this in order to competently answer the doctor when he refuses to prescribe the drug). Send letters by registered mail or take them in person and receive a mark that the letter has been accepted.

7. At a time when you are not being prescribed or given a prescribed medicine at a pharmacy, and you are in correspondence with officials, you buy the drug yourself, fold the receipts. If, according to the results of the correspondence, you still do not receive the drug, an equally lengthy stage begins - the trial.

8. Apply to the court at the place of residence or at the location of the Ministry of Health with a claim for the recovery of all spent Money for the purchase medicines and also put forward a demand for forced bidding for the purchase of a medicine for you if they are not held. It is necessary to attach to the statement of claim all cash and sales receipts, letters that you sent to the clinic, to the Ministry of Health, and the answers received, discharge epicrises from the hospital, appointments of specialized specialists (I have a gastroenterologist and an endocrinologist). If you have any travel expenses, please include receipts as well. You can make claims for compensation for moral damages. Present the originals of all checks and letters in court personally to the judge, do not send by mail: they may be lost.

Complaints about the doctors of the polyclinic should not be written. They are not to blame: it is such a system in Russia that the Ministry of Health has no money.

The Vital and Essential Drugs List 2020 is a registry of vital and essential medicines. It is approved by the Government of the Russian Federation in order to control and regulate the pricing of medicines. We figure out when it may be needed and how to find a list of essential drugs, as well as what a register of maximum allowable prices is.

Register of vital and essential medicines

The Vital and Essential Drug List is a list of medicines that is annually approved by the Government of the Russian Federation and maintained by the Ministry of Health of the Russian Federation. Let's figure out what is the difference between the lists of Vital and Essential Drugs and Vital and Essential Drugs. Until 2011, inclusive, the register of vital and essential medicines was called Vital and Essential Drugs, that is, the list of medicines, which defined medicines more broadly. Since 2012, the name of the list is Vital and Essential Drugs (drugs). It includes medicines under their own INN, that is, international non-proprietary names. These drugs are needed to provide medical care in any area of ​​activity of medical institutions. You can download the list of vital drugs for 2020, which is now called vital and essential drugs, on our website.

The state continuously controls the drug market, pricing for them and the economic efficiency of drug circulation. The key instrument of state control is the development of a list of vital and essential medicines.

You can view the list of Vital and Essential Drugs for 2020 at the government’s order No. 2738-r dated 12/10/2018.

The Ministry of Health of the Russian Federation is responsible for creating the list, as well as for processing and analyzing data on the efficacy and safety of drugs sold.

Register of maximum selling prices

State regulation of the drug market is primarily aimed at controlling the pricing of vital and essential drugs. An instrument of state regulation in this case the formation of a list of marginal selling prices for medicines.

The marginal price (PC) is the cost value that the manufacturer determines for a particular drug. It is fixed during registration or re-registration of the drug. It includes the following types of costs for the manufacturer:

• raw materials;
• materials;
• wage employees involved in the production process;
• Communal expenses;
• overhead and general business expenses;
• inflation rate;
• other costs.

The calculation of the PC is carried out in accordance with the methodology enshrined in the Resolution of the Russian Federation No. 979 dated September 15, 2015. Then the manufacturer registers the marginal prices for medicines in accordance with the regulations established by Decree of the Government of the Russian Federation No. 865 dated 10/29/2010. All medicines are included in the state register, excluding value added tax.

In order to exercise the function of state control over the circulation of the medicines market and the formation of prices for vital medicines, the Government of the Russian Federation has developed a register of maximum selling prices - a generalized statement of cost indicators for all medicines that are included in the 2020 list of essential drugs (part 1 of article 62 61-FZ) .

The Ministry of Health of the Russian Federation is also involved in the development and maintenance of the state register of maximum allowable prices. The specialists of the Ministry of Health form the list on the basis of the data provided by drug manufacturers when registering PCs for them.

In the event that the cost set by the manufacturer exceeds the standard fixed in the PC registry, the medical product is not entitled to be sold at such a cost indicator. If the price characteristic is not registered at all by the manufacturer, then the medication is not subject to sale.

You can view the list of essential drugs for 2020 along with the maximum selling prices on the official website of the Ministry of Health of the Russian Federation.

Features of public procurement of medicines included in the Vital and Essential Drugs Register

The purchase of medicines is subject to special requirements established at the legislative level. Customer when compiling terms of reference and conducting trading procedures must be guided by the provisions of 44-FZ.

So, if an organization purchases medicines included in the Vital and Essential Drugs list, and during the procedure it finds out that the maximum selling price for medicines offered by one of the participants is not registered (it is not displayed in the register of the PC) or the value of the lots exceeds the PC, and if if the price characteristic is reduced, the participant refuses to conclude a contract, then the customer has the right to remove such a bidder or refuse to conclude a contract with the winner of the public procurement (part 10 of article 31 44-FZ).

Thus, when purchasing medicines included in the Vital and Essential Drug List, the customer, in accordance with paragraph 2 of part 10 of Art. 31 44-FZ, is obliged to compare the prices (excluding VAT) of the purchased drugs offered by all bidders with the values ​​for each item from the PC register. If the price indicator exceeds the PV, then the participant is obliged to reduce at least to the value indicated in the register. In the event that a potential supplier refuses to reduce price positions, then the customer organization must refuse to conclude a contract with such a participant, having formed an appropriate protocol no later than one business day and sending it to the winner within a period not exceeding 2 business days (part 11 of Art. 31 44-FZ).

Ask questions, and we will supplement the article with answers and explanations!

Approved:

• list of vital and essential medicines for medical use for 2018 (Appendix 1 to the Order);
• list of medicinal products for medical use, including medicinal products for medical use, prescribed by decision of medical commissions medical organizations(Appendix 2 to the Order);
• a list of medicines intended to provide people with hemophilia, cystic fibrosis, pituitary dwarfism, Gaucher disease, malignant neoplasms
  lymphoid, hematopoietic and related tissues, multiple sclerosis, as well as persons after transplantation of organs and (or) tissues (Appendix 3 to the Order);
• the minimum range of medicines necessary for the provision of medical care (Appendix 4 to the Order).

You can read the text of the order in the box below. If the document is not displayed, then for review, follow the links: Order of Vital and Essential Drugs for 2018 on the website of the Government of the Russian Federation, or download.

Document help.

In accordance with the Decree of the Government of August 28, 2014 No. 871, the Government of Russia approves:

• a list of vital and essential drugs for medical use (hereinafter - VED);
• a list of medicinal products for medical use, including medicinal products for medical use, prescribed by decision of medical commissions of medical organizations;
• a list of drugs intended to provide persons with hemophilia, cystic fibrosis, pituitary dwarfism, Gaucher disease, malignant neoplasms of lymphoid, hematopoietic and related tissues, multiple sclerosis, persons after organ and (or) tissue transplantation;
• the minimum range of drugs needed to provide medical care.

The list of Vital and Essential Drugs is approved annually, other lists - at least once every three years.

The list of Vital and Essential Drugs for 2017 was approved by Government Decree No. 2885-r dated December 28, 2016. Lists of expensive drugs, drugs to ensure certain categories citizens and the minimum assortment were approved by the Government Decree of December 26, 2015 No. 2724-r.

The signed order approved the list of Vital and Essential Drugs for 2018.

The Vital and Essential Drugs List has been supplemented with 60 drugs and 8 new dosage forms for drugs already included in this list.

The list of medicines to provide certain categories of citizens has been supplemented with 25 medicines, 2 new dosage forms for medicines already included in this list.

The list of expensive drugs has been supplemented with 3 drugs (nonacog alfa for the treatment of patients with hemophilia, teriflunomide for the treatment of patients with multiple sclerosis, eliglustat for the treatment of persons suffering from type I Gaucher disease).

The minimum range of medicines required for the provision of medical care includes 3 additional medicines.

The decisions made are aimed at implementing federal laws dated April 12, 2010 No. 61-FZ "On the circulation of medicines", dated November 21, 2011 No. 323-FZ "On the basics of protecting the health of citizens in Russian Federation» in terms of providing Russian citizens with medicines included in the Vital and Essential Drugs List, and state regulation of prices for these medicines.

60 new drugs will receive the status of Vital and Essential Drugs and 6 drugs will leave the list.

60 new drugs will receive the status of Vital and Essential Drugs

The updated list of vital and essential drugs was supplemented by 60 new drugs. True, one of them can be called new only conditionally. Last year's list included INN N-carbamoylmethyl-4-phenyl-2-pyrrolidone in two forms: tablets and film-coated tablets. In the 2018 list, the chemical structural name active substance N-carbamoylmethyl-4-phenyl-2-pyrrolidone was changed to the nominal INN of phenylpiracetam. Lekforma remained unchanged. Among the new products in the list of Vital and Essential Drugs in 2018, anticancer drugs account for the most part - 22 INNs.

Six drugs will leave the list of Vital and Essential Drugs

Six drugs from last year's VED list were not included in the new list. Among those excluded from the list, two positions are systemic antiviral drugs for HIV therapy, one hypoglycemic drug, and one anti-asthma drug. The list of exceptions also included the antitumor drug of monoclonal antibodies in combinations and estradiol.

Vital and essential drug lekforms: plus 20 and minus 17 positions

In the updated list of Vital and Essential Drugs, the Government included 20 new lekforms, one for 19 INNs and two for bosentan. Eight of the 20 lekforms are injectable, 11 are oral, including two with extended release (valproic acid granules and fenspiride tablets). Dexamethasone received a new lekform - an implant for intravitreal injection.

The government excluded from the list of Vital and Essential Drugs one form for 17 INNs. The new list, in particular, did not include fentanyl sublingual tablets, tramadol oral drops, ritonavir soft capsules. Excluded from the new list and capsules of prolonged action of nitroglycerin.

Minimum assortment - minimum changes

The Government has added amlodipine tablets and fluconazole capsules to the list of minimum assortment for pharmacies of industrial and finished dosage forms. In addition, for INN oseltamivir, the suspension for oral administration was excluded from the list, leaving only the lekform “capsules”. For atorvastatin tablets, an alternative has emerged. Pharmacies may choose to include coated tablets or film-coated tablets in the minimum range. Changes in the minimum assortment do not apply to pharmacies, kiosks and individual entrepreneurs. For them, the list remains the same.

Table 1. New drugs to be included in the list of Vital and Essential Drugs in 2018

Table 2. Drugs excluded from the 2018 Vital and Essential Drug List

Table 3. Drugs for which the number of lekforms will increase in 2018

Table 4. Drugs for which there will be fewer dosage forms in 2018

Prime Minister Dmitry Medvedev approved the list of vital and essential medicines for medical use (VED) for 2018. The corresponding order, prepared by the Ministry of Health, was published on the Government website on October 23.

Government Decree No. 2323 r dated October 23, 2017 approved lists of vital and essential drugs, drugs prescribed by decision of the medical commission, drugs from the “7 nosologies” program, as well as a list of the minimum range of medicines.

Summary table of new INNs included in the list of Vital and Essential Drugs for 2018

Materials about Vital and Essential Drugs and other lists: